Context Capital Management, LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1301396
LAJOLLA, CA
Position in LGND
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$14,540,140
New position
Shares Held
46,000
first reported quarter
Ownership
0.231%
of shares outstanding
% of Portfolio
3.20%
of 13F equity value
Holder Rank
#71
of 411 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Context Capital Management, LLC holds $19,316,305 across 2 Biotechnology names. LGND ranks #1 (75.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
46,000 | $14,540,140 | |
| 2 | GOSS |
Gossamer Bio, Inc.
|
28,946,459 | $4,776,165 |
All Filings in LGND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,540,140 | 46,000 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||